Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
330
-
Total 13F shares, excl. options
-
86.6M
-
Shares change
-
+422K
-
Total reported value, excl. options
-
$6.74B
-
Value change
-
+$38M
-
Put/Call ratio
-
0.13
-
Number of buys
-
148
-
Number of sells
-
-178
-
Price
-
$77.87
Significant Holders of RESMED INC - COM (RMD) as of Q2 2017
403 filings reported holding RMD - RESMED INC - COM as of Q2 2017.
RESMED INC - COM (RMD) has 330 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.6M shares
.
Largest 10 shareholders include BlackRock Inc. (14.2M shares), VANGUARD GROUP INC (11.9M shares), Capital World Investors (10.1M shares), FMR LLC (5.54M shares), BAILLIE GIFFORD & CO (4.87M shares), STATE STREET CORP (4.61M shares), Bank of New York Mellon Corp (2.27M shares), COMMONWEALTH BANK OF AUSTRALIA (1.98M shares), NORTHERN TRUST CORP (1.47M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.24M shares).
This table shows the top 330 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.